2-deoxy-D-ribose | CAS:533-67-5

We serve 2-deoxy-D-ribose CAS:533-67-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-deoxy-D-ribose

Chemical Name:2-deoxy-D-ribose
CAS.NO:533-67-5
Synonyms:2-deoxy-D-ribose
2-Deoxy-D-arabinose
2-Doxy-D-Ribose
D-deoxyribose
2-deoxy-D-erythro-pentose
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 379.7±42.0 °C at 760 mmHg
Melting Point 89-90 °C(lit.)
Molecular Formula C5H10O4
Molecular Weight 134.130
Flash Point 197.6±24.4 °C
Vapour Pressure 0.0±1.9 mmHg at 25°C
Index of Refraction 1.500
 
Specification:
Appearance:White to off-white powder
Assay(HPLC):≥98.0%
Melting Point:79-80°C
Specific rotation:-54°~-57°
Loss on drying:≤0.5%
Residue on ignition:≤0.5%
Heavy metals:≤10ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Decitabine(CAS:2353-33-5) and Azacitidine(CAS:320-67-2).



Contact us for information like 2-deoxy-D-ribose chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-deoxy-D-erythro-pentose physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Deoxy-D-arabinose Use and application,2-Doxy-D-Ribose technical grade,usp/ep/jp grade.


Related News: The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.methyl pyridine-4-carboxylate manufacturer Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.2,3,5,6-Tetrachloropyridine supplier The US National Institutes of Health is working on a preventative vaccine, but it will likely take a few months until the first phase of clinical trials get underway, and more than a year until a vaccine might be available, according to experts.Phenylacetone vendor Dr Maria Van Kerkhove, of the WHO’s emerging diseases unit, says it is important that you keep up basic hand and respiratory hygiene, such as washing your hands with soap and water and sneezing into your elbow or a tissue.Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.